Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Christian Grätz Insider Profile
4 Followers
Christian Grätz, Market Operations Director at Allergy Therapeutics, holds 510.66K shares in Allergy Therapeutics (Ticker: GB:AGY). Most recently, Christian Grätz ― shares of Allergy Therapeutics on ― for an estimated value of ―.
Christian Grätz has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Market Operations Director
Roles that Christian Grätz holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Christian Grätz
Christian Grätz's Trading History
List of latest transactions for each holding click on a transaction to see Christian Grätz's performance on stock
You May Also Like
Christian Grätz insider profile FAQ
What is the percentage of profitable transactions made by Christian Grätz?
The percentage of profitable transactions made by Christian Grätz is ―.
What is the average return per transaction made by Christian Grätz?
The average return per transaction made by Christian Grätz is ―.
What stocks does Christian Grätz hold?
Christian Grätz holds: GB:AGY stocks.
What was Christian Grätz’s latest transaction?
Christian Grätz latest transaction was an Uninformative Buy of ―.
What was Christian Grätz's most profitable transaction?
Christian Grätz’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Christian Grätz's role in Allergy Therapeutics?
Christian Grätz's role in Allergy Therapeutics is Market Operations Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.